Digital Look

Welcome to Digital Look++,
you are not logged in

Argent Biopharma Limited NPV (DI) (RGT)

Pharma and Biotech

21.00p

Trade now with Barclays Stockbrokers

2024-04-03 - Suspension of Listing

Year Ending	Revenue ($m)	Pre-tax ($m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
30-Jun-20	2.08	(18.77)	(13.73)¢	n/a	n/a	n/a	n/a	0.0%
30-Jun-21	3.00	(15.90)	(81,000.00)¢	n/a	n/a	n/a	n/a	0.0%
30-Jun-22	4.73	(20.77)	(79,000.00)¢	n/a	n/a	n/a	n/a	0.0%
30-Jun-23	3.39	(21.13)	(71,000.00)¢	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Dr. Shlomo Sadoun Joins Advisory Board	15-Apr-2024	07:00	RNS
PDMR Notification	10-Apr-2024	16:30	RNS
Suspension - MGC Pharmaceuticals Limited	03-Apr-2024	07:30	RNS

No recent information was found.

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.